195 results
Page 2 of 10
8-K
EX-99.1
tlk8td9
14 Sep 22
Caladrius Biosciences Announces Approval of Merger and Name Change to Lisata Therapeutics
5:01pm
425
02m cohevo7q
2 Sep 22
Business combination disclosure
4:01pm
425
wpqa6k
15 Aug 22
Business combination disclosure
6:46am
425
w1tn4sn
10 Aug 22
Business combination disclosure
8:08am
8-K
EX-99.3
v7ki2clel
5 Aug 22
Caladrius Biosciences Reports Second Quarter 2022 Financial Results and Provides Business Update
4:01pm
8-K
EX-99.1
42n5d4sbjxpoqnudu
5 Aug 22
Caladrius Biosciences Reports Second Quarter 2022 Financial Results and Provides Business Update
4:01pm
424B3
et1chx4m0b4r
29 Jul 22
Prospectus supplement
4:06pm
425
ss5tzx6xhhvcyjv0l9o
6 Jul 22
Business combination disclosure
4:05pm
425
dbh yalloze32
9 Jun 22
Business combination disclosure
4:01pm
8-K
EX-99.1
pfoca5r xw
23 May 22
Caladrius Biosciences Provides Update on Phase 2b FREEDOM Trial of XOWNA® in Coronary Microvascular Dysfunction
4:08pm
8-K
EX-99.2
ousbxavlf6q2yz52rfrn
23 May 22
Caladrius Biosciences Provides Update on Phase 2b FREEDOM Trial of XOWNA® in Coronary Microvascular Dysfunction
4:08pm
8-K
EX-99.1
41abb7086 om1aw1d
5 May 22
Caladrius Biosciences Reports First Quarter 2022 Financial Results and Provides Business Update
12:00am
8-K
EX-99.2
sdl0v7 mgl
5 May 22
Caladrius Biosciences Reports First Quarter 2022 Financial Results and Provides Business Update
12:00am
8-K
EX-99.1
hptiom85usdaaw2u6urc
27 Apr 22
Caladrius Biosciences and Cend Therapeutics Announce
7:05am
8-K
EX-99.1
he91pv29poblpzbrtu
22 Mar 22
Caladrius Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
4:09pm
8-K
EX-99.2
34zj gceixje3rgc8zd
22 Mar 22
Caladrius Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
4:09pm